These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15318223)

  • 1. Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel.
    Bouzat C; Gumilar F; Spitzmaul G; Wang HL; Rayes D; Hansen SB; Taylor P; Sine SM
    Nature; 2004 Aug; 430(7002):896-900. PubMed ID: 15318223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
    Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK
    Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel.
    Lummis SC; Beene DL; Lee LW; Lester HA; Broadhurst RW; Dougherty DA
    Nature; 2005 Nov; 438(7065):248-52. PubMed ID: 16281040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of single-channel conductance and ion selectivity in the Cys-loop family: insights from the 5-HT3 receptor.
    Peters JA; Hales TG; Lambert JJ
    Trends Pharmacol Sci; 2005 Nov; 26(11):587-94. PubMed ID: 16194573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.
    Connolly CN; Wafford KA
    Biochem Soc Trans; 2004 Jun; 32(Pt3):529-34. PubMed ID: 15157178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different structural requirements for functional ion pore transplantation suggest different gating mechanisms of NMDA and kainate receptors.
    Villmann C; Hoffmann J; Werner M; Kott S; Strutz-Seebohm N; Nilsson T; Hollmann M
    J Neurochem; 2008 Oct; 107(2):453-65. PubMed ID: 18710418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytoplasmic region determines single-channel conductance in 5-HT3 receptors.
    Kelley SP; Dunlop JI; Kirkness EF; Lambert JJ; Peters JA
    Nature; 2003 Jul; 424(6946):321-4. PubMed ID: 12867984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of channel gating of the ligand-gated ion channel superfamily inferred from protein structure.
    Absalom NL; Lewis TM; Schofield PR
    Exp Physiol; 2004 Mar; 89(2):145-53. PubMed ID: 15123543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
    Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
    Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain.
    Ludwig J; Höffle-Maas A; Samochocki M; Luttmann E; Albuquerque EX; Fels G; Maelicke A
    J Recept Signal Transduct Res; 2010 Dec; 30(6):469-83. PubMed ID: 21062106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-hydroxytryptamine type 3 (5-HT3) receptor reveals a novel determinant of single-channel conductance.
    Peters JA; Kelley SP; Dunlop JI; Kirkness EF; Hales TG; Lambert JJ
    Biochem Soc Trans; 2004 Jun; 32(Pt3):547-52. PubMed ID: 15157181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening the pore hinges on proline.
    Andreotti AH
    Nat Chem Biol; 2006 Jan; 2(1):13-4. PubMed ID: 16408084
    [No Abstract]   [Full Text] [Related]  

  • 13. Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states.
    Gumilar F; Bouzat C
    Eur J Pharmacol; 2008 Apr; 584(1):30-9. PubMed ID: 18314100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptors.
    Peters JA; Carland JE; Cooper MA; Livesey MR; Deeb TZ; Hales TG; Lambert JJ
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):882-6. PubMed ID: 17052220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pore conformations and gating mechanism of a Cys-loop receptor.
    Paas Y; Gibor G; Grailhe R; Savatier-Duclert N; Dufresne V; Sunesen M; de Carvalho LP; Changeux JP; Attali B
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15877-82. PubMed ID: 16247006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
    Solt K; Stevens RJ; Davies PA; Raines DE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nicotinic acetylcholine receptor of the Torpedo electric ray.
    Unwin N
    J Struct Biol; 1998; 121(2):181-90. PubMed ID: 9615437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of glutamate receptor desensitization.
    Sun Y; Olson R; Horning M; Armstrong N; Mayer M; Gouaux E
    Nature; 2002 May; 417(6886):245-53. PubMed ID: 12015593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiology: triggers for channel opening.
    Czajkowski C
    Nature; 2005 Nov; 438(7065):167-8. PubMed ID: 16281019
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.
    Pegan S; Arrabit C; Zhou W; Kwiatkowski W; Collins A; Slesinger PA; Choe S
    Nat Neurosci; 2005 Mar; 8(3):279-87. PubMed ID: 15723059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.